Estadísticas
Número total de visitas
| Visualizaciones | |
|---|---|
| Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Lacticaseibacillus rhamnosus CRL1505 in the prevention of upper respiratory tract infections in a healthy pediatric population | 608 |
Visitas al mes
| febrero 2026 | marzo 2026 | abril 2026 | mayo 2026 | junio 2026 | julio 2026 | agosto 2026 | |
|---|---|---|---|---|---|---|---|
| Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Lacticaseibacillus rhamnosus CRL1505 in the prevention of upper respiratory tract infections in a healthy pediatric population | 32 | 28 | 41 | 59 | 55 | 43 | 24 |
Visitas al fichero
| Visualizaciones | |
|---|---|
| Registro IRESP.PROB 2.pdf | 219 |
Países con más visualizaciones
| Visualizaciones | |
|---|---|
| Estados Unidos | 172 |
| Alemania | 80 |
| Singapur | 71 |
| Hong Kong | 45 |
| Brasil | 38 |
| Irlanda | 22 |
| Reino Unido | 21 |
| Vietnam | 20 |
| España | 15 |
| México | 14 |
Ciudades con más visualizaciones
| Visualizaciones | |
|---|---|
| Frankfurt am Main | 76 |
| Ashburn | 63 |
| Hong Kong | 43 |
| Council Bluffs | 24 |
| Dublin | 22 |
| San Jose | 14 |
| Singapore | 13 |
| Hanoi | 9 |
| Mexico City | 8 |
| Santafé | 8 |




